TXMD
TherapeuticsMD, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$2.21
−1.34%Margins
Gross margin
89.9%
EBITDA margin
-128.3%
EBIT margin
-117.8%
Net margin
-6.6%
FCF margin
95.4%
-0.8%
Return on equity
-0.6%
Return on assets
-11.8%
Return on invested capital
0.09x
Asset turnover
$3.1M
Cash from operations
$0.79
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026